Jesse D. Vargas

2.0k total citations · 1 hit paper
17 papers, 1.5k citations indexed

About

Jesse D. Vargas is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Jesse D. Vargas has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Jesse D. Vargas's work include RNA Research and Splicing (6 papers), Immune Response and Inflammation (4 papers) and NF-κB Signaling Pathways (4 papers). Jesse D. Vargas is often cited by papers focused on RNA Research and Splicing (6 papers), Immune Response and Inflammation (4 papers) and NF-κB Signaling Pathways (4 papers). Jesse D. Vargas collaborates with scholars based in United States, Australia and Finland. Jesse D. Vargas's co-authors include Alexander Hoffmann, Simon Mitchell, Daniel J. Anderson, Martin W. Hetzer, Emily M. Hatch, Cheng Zhang, Andrew B. Caldwell, Kenneth J. Shea, Steven M. Sparks and Mary-Kamala Menon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and The Journal of Cell Biology.

In The Last Decade

Jesse D. Vargas

17 papers receiving 1.5k citations

Hit Papers

Signaling via the NFκB system 2016 2026 2019 2022 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesse D. Vargas United States 13 849 387 283 170 128 17 1.5k
Boxu Ren China 19 550 0.6× 226 0.6× 146 0.5× 139 0.8× 140 1.1× 33 1.3k
Sonia Shalini Australia 16 929 1.1× 281 0.7× 150 0.5× 179 1.1× 171 1.3× 19 1.6k
Yuhui Yang China 14 723 0.9× 462 1.2× 240 0.8× 98 0.6× 327 2.6× 23 1.6k
Jang Hee Hong South Korea 26 926 1.1× 201 0.5× 249 0.9× 108 0.6× 176 1.4× 96 1.7k
Ha Young Lee South Korea 23 1.1k 1.3× 541 1.4× 180 0.6× 81 0.5× 211 1.6× 63 1.7k
Takashi Tanikawa Japan 15 553 0.7× 358 0.9× 176 0.6× 89 0.5× 191 1.5× 50 1.2k
Amanda Tomie Ouchida Sweden 12 811 1.0× 164 0.4× 259 0.9× 101 0.6× 146 1.1× 13 1.3k
Chang‐Yan Li China 21 905 1.1× 206 0.5× 186 0.7× 93 0.5× 127 1.0× 81 1.5k

Countries citing papers authored by Jesse D. Vargas

Since Specialization
Citations

This map shows the geographic impact of Jesse D. Vargas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse D. Vargas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse D. Vargas more than expected).

Fields of papers citing papers by Jesse D. Vargas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse D. Vargas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse D. Vargas. The network helps show where Jesse D. Vargas may publish in the future.

Co-authorship network of co-authors of Jesse D. Vargas

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse D. Vargas. A scholar is included among the top collaborators of Jesse D. Vargas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse D. Vargas. Jesse D. Vargas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cheng, Cheng, Henri Leinonen, Hong Yin, et al.. (2022). VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy. Journal of Translational Medicine. 20(1). 21–21. 12 indexed citations
2.
LeBlanc, Amy K., Christina Mazcko, Timothy M. Fan, et al.. (2022). Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs. Molecular Cancer Therapeutics. 21(10). 1510–1523. 6 indexed citations
3.
Fiskus, Warren, Christopher P. Mill, Christine Birdwell, et al.. (2022). Efficacy of Vcp/p97 Inhibitor, CB-5339, Alone and in Combinations Against High-Risk AML, Including Those with Genetic Lesion in TP53. Blood. 140(Supplement 1). 8807–8808. 2 indexed citations
4.
Leinonen, Henri, Cheng Cheng, Marja Pitkänen, et al.. (2021). A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6. Journal of Pharmacology and Experimental Therapeutics. 378(1). 31–41. 26 indexed citations
6.
Assimon, Victoria A., Jesse D. Vargas, Grace J. Lee, et al.. (2019). CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity. ACS Chemical Biology. 14(2). 236–244. 63 indexed citations
7.
Vargas, Jesse D., Nadja Kern, Gerard Kroon, et al.. (2017). Functional importance of stripping in NFκB signaling revealed by a stripping-impaired IκBα mutant. Proceedings of the National Academy of Sciences. 114(8). 1916–1921. 30 indexed citations
8.
Mitchell, Simon, Jesse D. Vargas, & Alexander Hoffmann. (2016). Signaling via the NFκB system. WIREs Systems Biology and Medicine. 8(3). 227–241. 807 indexed citations breakdown →
9.
Shokhirev, Maxim N., et al.. (2015). A multi‐scale approach reveals that NF‐κB cR el enforces a B‐cell decision to divide. Molecular Systems Biology. 11(2). 783–783. 26 indexed citations
10.
Fagerlund, Riku, et al.. (2015). Anatomy of a negative feedback loop: the case of I κ B α. Journal of The Royal Society Interface. 12(110). 20150262–20150262. 25 indexed citations
11.
Vargas, Jesse D., et al.. (2015). Limited specificity of IRF3 and ISGF3 in the transcriptional innate-immune response to double-stranded RNA. Journal of Leukocyte Biology. 98(1). 119–128. 26 indexed citations
12.
Caldwell, Andrew B., et al.. (2014). Network dynamics determine the autocrine and paracrine signaling functions of TNF. Genes & Development. 28(19). 2120–2133. 71 indexed citations
13.
Vargas, Jesse D., et al.. (2014). DEAF1 Binds Unmethylated and Variably Spaced CpG Dinucleotide Motifs. PLoS ONE. 9(12). e115908–e115908. 9 indexed citations
14.
Vargas, Jesse D., Emily M. Hatch, Daniel J. Anderson, & Martin W. Hetzer. (2012). Transient nuclear envelope rupturing during interphase in human cancer cells. Nucleus. 3(1). 88–100. 197 indexed citations
15.
Anderson, Daniel J., et al.. (2009). Recruitment of functionally distinct membrane proteins to chromatin mediates nuclear envelope formation in vivo. The Journal of Cell Biology. 186(2). 183–191. 87 indexed citations
16.
Anderson, Daniel J., et al.. (2009). Recruitment of functionally distinct membrane proteins to chromatin mediates nuclear envelope formation in vivo. The Journal of Cell Biology. 186(6). 929–929. 85 indexed citations
17.
Sparks, Steven M., Jesse D. Vargas, & Kenneth J. Shea. (2000). Type 2 Intramolecular Nitroso Diels−Alder Reaction. Synthesis and Structure of Bridgehead Oxazinolactams. Organic Letters. 2(10). 1473–1475. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026